do glp 1 drugs cause cancer Glucagon-like peptide receptor agonists and risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research Can GLP-1 Drugs Reduce Cancer

Many GLP-1RAs are modified at this position to provide protection against DPP-4 degradation

At the same time, they reduce appetite by interacting with hunger signals in the brain, leading to significant weight loss

Of particular interest, the discovery of GLP-1 receptor expression in the myocardium and in the vascular endothelium suggested possible roles of GLP-1 in the cardiovascular system and multiple preclinical studies support cardioprotective effects of native GLP-1 (Fig

The REWIND trial suggested that dulaglutide might be effective for both primary and secondary cardiovascular prevention in individuals with T2DM (254)

Diabetes Care 39 , 912923 (2016)

Liu Y, Ruan B, Jiang H, Le S, Liu Y, Ao X, et al